CK Life Sciences Int'l (Holdings) Inc 2016 AR2
The report outlines the performance of CK Life Sciences Int'l., (Holdings) Inc. for the year ended 31 December 2016. The company reported a profit attributable to shareholders of HK$252 million, representing a 15% increase compared to 2015. Its agriculture-related business recorded a profit of HK$310 million, and the nutraceutical business contributed HK$398 million. In pharmaceutical R&D, WEX Pharmaceuticals progressed with tetrodotoxin clinical trials for cancer pain, while Polynoma advanced its melanoma vaccine Phase III trials. Additionally, the company published its first Environmental, Social and Governance report, highlighting its approach to sustainability, resource efficiency, and community investment.
Company: CK Life Sciences Int'l (Holdings) Inc
Sector: Manufacturing
Country: Hong Kong
Year: 2016
Type: AR2
Pages: 176
Back to company
CK Life Sciences Int'l (Holdings) Inc
Annual Report
The report outlines the performance of CK Life Sciences Int'l., (Holdings) Inc. for the year ended 31 December 2016. The company reported a profit attributable to shareholders of HK$252 million, representing a 15% increase compared to 2015. Its agriculture-related business recorded a profit of HK$310 million, and the nutraceutical business contributed HK$398 million. In pharmaceutical R&D, WEX Pharmaceuticals progressed with tetrodotoxin clinical trials for cancer pain, while Polynoma advanced its melanoma vaccine Phase III trials. Additionally, the company published its first Environmental, Social and Governance report, highlighting its approach to sustainability, resource efficiency, and community investment.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2016
Reporting Period
Jan 1, 2016 - Dec 31, 2016
Fiscal Year
2016
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees